Key result
Highest TyG index quartile linked to ~5.7-fold higher incident CVD risk in non-diabetic adults.
Why the study?
Early markers of cardiovascular risk should be identified before the onset of overt metabolic disorders in non-diabetic adults without established CVD.
Does a higher triglyceride-glucose (TyG) index predict incident cardiovascular disease in non-diabetic adults without established CVD?
Cohort (n=553)
Yes
Does a higher triglyceride-glucose (TyG) index predict incident cardiovascular disease in non-diabetic adults without established CVD?
Hazard Ratio: 5.728 (95% CI 2.845–11.53)
Absolute Event Rate: 39.1% vs 7.2%
p-value: p=<0.001
The triglyceride-glucose (TyG) index is independently associated with an increased incidence of cardiovascular disease in non-diabetic adults, presenting a potential complementary, low-cost marker for early cardiovascular risk assessment.
TyG index was associated with incident CVD in non-diabetics; hypothesis-generating and requires prospective validation before risk stratification use.
BACKGROUND: Cardiovascular disease (CVD) often develops silently; therefore, early markers of cardiovascular risk should be identified before the onset of overt metabolic disorders. The study evaluated the association between the triglyceride-glucose (TyG) index and incident CVD among non-diabetic adults without established CVD. METHODS: A total of 553 non-diabetic adults without established CVD were recruited using non-probability convenience sampling from tertiary care centres and followed for 12-29 months. We collected demographic, clinical, and laboratory parameters, and computed the TyG index from fasting triglyceride and glucose levels. A total of 125 (22.6%) participants developed incident CVD during follow-up. RESULTS: We observed a clear dose-response relationship, with 10/139 (7.2%) participants in the lowest TyG quartile and 54/138 (39.1%) participants in the highest TyG quartile developing incident CVD. After adjustment for age, gender, BMI, smoking status, hypertension, physical activity, and family history of CVD, the TyG index remained strongly associated with incident CVD (adjusted HR = 4.597, p < 0.001), while only hypertension remained statistically significant. The receiver operating characteristic curve analysis demonstrated moderate discriminative ability for incident CVD (area under the curve (AUC): 0.694). CONCLUSION: The results suggest that the TyG index may serve as a complementary, low-cost marker for cardiovascular risk assessment in non-diabetic individuals; however, its moderate discriminative ability and lack of demonstrated incremental prognostic value warrant further validation.
No takes yet. Share an insight, caveat, or question.
Faisal et al. (2026) conducted a cohort in Non-diabetic adults without established cardiovascular disease (n=553). Triglyceride-glucose (TyG) index vs. Lowest TyG index quartile (Q1) was evaluated on Incident cardiovascular disease (myocardial infarction, stroke, angina, and documented coronary artery disease) (HR 5.728, 95% CI 2.845-11.530, p=<0.001). Higher triglyceride-glucose (TyG) index was strongly associated with increased incident cardiovascular disease in non-diabetic adults, with those in the highest quartile facing a 5.7-fold higher adjusted risk compared to the lowest quartile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: